Does Your Japan Partner Have an Economic Reason to Innovate?

Foreign technology companies entering Japan are often advised to find a local partner. The logic is sound. A partner can provide credibility, customer access, regulatory understanding and relationships that would otherwise take years to build.

But there is another question that receives much less attention:

If the technology succeeds exactly as intended, what happens to the partner’s existing economics?

Does the partner earn more? Does it gain a new source of revenue? Does it strengthen an existing customer relationship? Or does the technology automate, simplify or bypass something the partner is currently paid to do?

That question matters because a company can be strategically enthusiastic about innovation while remaining economically invested in the model the innovation is supposed to change. In Japan’s insurance sector, that tension is becoming increasingly visible.

Not every partner is economically positioned to drive change

The word partner can hide very different business models. A consulting firm advising a client on transformation is generally paid because something changes. A systems integrator may benefit when new technology creates implementation, integration and managed-service work. A technology reseller may earn incremental revenue when a new product is sold.

For those partners, innovation can expand the addressable revenue pool.

An intermediary whose economics depend primarily on the existing transaction is in a different position. If revenue is linked to product commissions, manual intermediation, existing distribution arrangements or activities that a new technology is intended to reduce, then the commercial equation changes.

The partner may genuinely believe the technology is valuable. Its management may genuinely support innovation. Its customers may benefit. But the organisation still has to answer a harder internal question: why should we allocate resources to something that may reduce the value of what we already do?

This is not uniquely Japanese, and it would be misleading to describe it as resistance to innovation. It is a channel-conflict problem. What makes it especially relevant in Japan insurance is that the economics of intermediation are themselves under pressure to change.

Japan’s insurance intermediaries are already reconsidering their economics

Japan’s insurance distribution model is being pushed toward a different balance between sales volume, business quality and intermediary independence.

The Financial Services Agency’s current supervisory guidance states that non-life agency commission assessment should not be weighted excessively toward scale and revenue growth, and should instead place greater emphasis on business quality¹. The point is not that commission disappears. It is that the regulator is explicitly challenging incentive structures that can reward volume without adequately reflecting customer outcomes and conduct.

The industry discussion is also moving beyond regulation. In a 2026 PwC roundtable with executives from Japanese insurance agencies and brokers, participants discussed the limits of traditional commission-dependent models and the possibility of fee-based structures and broader risk-management roles². The discussion does not establish how the whole market will evolve, but it shows that the revenue model of the intermediary itself has become an active strategic question.

That matters to foreign technology companies because a partner’s appetite for innovation cannot be separated from what that partner is paid to do today.

Is the organisation being asked to commercialise the innovation also economically exposed to what the innovation replaces?

Customer value and channel value are not the same thing

Technology propositions are usually built around customer or insurer value: lower acquisition cost, faster underwriting, automated claims, reduced administrative work, more direct customer engagement, better use of data or fewer manual processes.

Those can all be compelling benefits. They do not necessarily create equal value for every participant in the existing chain.

Consider a technology company whose proposition reduces the cost of acquiring or servicing an insurance customer. From the insurer’s perspective, that may improve economics. From the customer’s perspective, it may improve speed or experience. From the technology company’s perspective, it demonstrates clear ROI.

But an intermediary may reasonably ask a different question:

Whose cost is being removed?

If part of that cost represents activity from which the intermediary earns revenue, the innovation has not simply created efficiency. It has redistributed economic value.

That does not mean the intermediary will oppose it. It means the proposition must answer a different commercial question: what replaces the value being removed?

Eveil View The more transformative a technology claims to be, the more carefully a foreign entrant should ask whose economics it is transforming. Customer value does not automatically become channel value.

This changes how partner enthusiasm should be interpreted

A foreign technology company can easily misread positive engagement. An innovation team likes the proposition. A senior executive sees strategic value. A pilot receives internal support. The partner agrees that the existing process needs to change.

All of those are useful signals. None establishes that the organisation has resolved the economic consequences of successful adoption.

That distinction becomes especially important when different parts of the partner organisation experience the innovation differently. Strategy may see future growth. Customer-facing teams may see a stronger proposition. Compliance may see better controls. Operations may see lower workload.

A sales organisation, however, may see reduced commission, additional complexity or a product that is harder to explain than the one already generating revenue. An internal agency or intermediary may see part of its historical role becoming less necessary.

There is no contradiction in all of these views being true at the same time. The mistake is assuming that executive support settles the commercial trade-off.

The strongest partner may have the greatest conflict

This creates an uncomfortable paradox for market entry.

The partner with the strongest customer relationships and greatest distribution access may also be the one most embedded in the economics the technology could disrupt.

That does not make it the wrong partner. In many cases, it may still be the only partner capable of taking the proposition to scale. But it changes what needs to be validated.

The conventional partner question is:

Can they take us to market?

The better question may be:

What happens to their business if they do?

If success increases the partner’s revenue, strengthens its customer position and creates additional services it can monetise, alignment may be relatively straightforward. If success primarily reduces costs elsewhere while increasing workload for the partner, alignment is weaker. If success makes part of the partner’s existing intermediation role unnecessary, the company should expect a much more complex adoption path.

The underlying technology can be equally good in all three cases. What changes is the incentive to commercialise it.

Innovation can stall after the pilot for rational reasons

This also offers another way to interpret a familiar pattern: the successful pilot that does not scale.

The common explanation is organisational inertia. Sometimes that is right. But a pilot and a scaled commercial model can have very different economics.

A pilot is typically funded as experimentation. Its success may be measured through engagement, operational feasibility, customer response or technical performance. The people involved are often explicitly responsible for innovation.

Commercialisation changes the questions. Which budget pays? Who earns the revenue? Who loses revenue? Who has to train the salesforce? Who absorbs ongoing support? Which existing product or service receives less attention? Does the partner need to redesign its own role before it can scale the new proposition?

At that point, what looked like a technology decision becomes a business-model decision.

A pilot can prove that the technology works without proving that the economics around it work.

Regulation may now be changing the equation

The timing is important because the economics of Japanese insurance intermediation are not static.

The FSA’s current direction places greater weight on customer outcomes, business quality and appropriate agency governance rather than relying heavily on scale and revenue growth in commission assessment¹. Industry participants are also discussing movement away from traditional commission dependence toward fee-based services, risk-management capabilities and more independent intermediary models².

None of this means that the existing model will disappear quickly. Nor does it mean that technology companies will automatically benefit.

But it may gradually change the commercial calculation. If an intermediary can earn revenue from risk advice, technology-enabled services, data, customer management or broader consulting rather than principally from the existing insurance transaction, innovation becomes less threatening to the revenue base.

In other words, regulatory reform may matter to foreign technology companies for a reason that is easy to miss. It can change not only what partners are allowed or required to do. It can change what they have an economic reason to do.

The relevant distinction may be additive versus substitutive innovation

This suggests a practical way to examine a technology proposition before selecting a Japan partner.

Some innovations are additive to the partner’s economics. They create something new the partner can sell, improve the value of an existing relationship, open a customer segment, generate implementation work or add a new revenue stream.

Others are more substitutive. They automate existing activity, move the customer relationship elsewhere, simplify intermediation, shift transactions direct or reduce the economic value of work currently performed by the partner.

Most real propositions sit somewhere between the two.

The distinction is not a judgement about which technology is better. A substitutive innovation may create far more customer value. But the commercialisation strategy should be different.

An additive proposition can often work through the existing incentive structure. A substitutive proposition may require the partner’s business model to change alongside the technology.

That is a much larger transformation.

This is where foreign entrants can choose the wrong partner for the right reasons

A foreign entrant naturally looks for reputation, customer access, industry knowledge and senior relationships. Those criteria identify powerful partners. They do not necessarily identify economically aligned ones.

A smaller or less obvious partner may sometimes have more reason to challenge the existing structure because it has more to gain from a new model. A technology-focused subsidiary may have incentives that differ from those of the parent company’s traditional distribution organisation. An insurer may see strategic value that an intermediary does not. A broker seeking to build advisory or fee-based revenue may view the same technology differently from an agency whose economics remain closely linked to commissions.

The relevant unit of analysis is therefore not simply the company.

It is the business model and organisational unit expected to make the innovation commercially real.

What remains uncertain Public evidence can show that Japanese insurance intermediation and commission structures are changing, but it cannot establish that Japanese partners are systematically less supportive of innovation than partners elsewhere. Nor does the evidence show that commission-based economics necessarily prevent technology adoption. The relevant question has to be tested partner by partner and proposition by proposition.

The question worth asking

When evaluating a Japan partner, foreign technology companies often ask whether the organisation understands the product, has customer access and is interested in collaboration. Those questions still matter.

But for a proposition that claims to transform how an industry works, one more should come first:

If this innovation succeeds exactly as intended, does the partner make more money, less money, or become less necessary?

If the partner makes more money, the route to alignment may be straightforward. If the answer is less clear, the company needs to understand where the economic value moves, who inside the organisation gains from that movement and who does not.

And if the technology weakens the partner’s existing role, the market-entry strategy cannot assume that enthusiasm for innovation will overcome the economics of the current model.

The issue is not whether the partner is innovative.

It is whether innovation and the partner’s business model point in the same direction.